- Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study
- No association of anti‑osteoporosis drugs with COVID‑19‑related outcomes in women: a nationwide cohort study
- Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity)
- Physical Activity Indicators, Metabolic Biomarkers, and Comorbidity in Type 2 Diabetes
- COVID-19 and the Futures of Machine Learning
- Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia)
- Turkish Adaptation of Michigan Diabetes Research and Training Center’s Revised Diabetes Knowledge Test and Determination of Factors Affecting the Knowledge Level of Diabetic Individuals
- Current State of “Omics” Biomarkers in Pancreatic Cancer
- WHAT ARE THE FACTORS AFFECTING THE FRAILTY OF ELDERLY PEOPLE WITH TYPE 2 DIABETES?
- Monogenic Childhood Diabetes: Dissecting Clinical Heterogeneity by Next-Generation Sequencing in Maturity-Onset Diabetes of the Young